Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Murthy

Showing results (761-770 of 873) with videos related to

Pageof 88
Sort By:
The Journal of Biological Chemistry|April 5, 2000
Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virusS Mummidi, M Bamshad, S S Ahuja, et al.
Infection Control and Hospital Epidemiology|December 9, 2020
Reliability of nonlocalizing signs and symptoms as indicators of the presence of infection in nursing-home residentsTheresa A Rowe, Robin L P Jump, Bjørg Marit Andersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2020
Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib StudyShanu Modi, Haeseong Park, Rashmi K Murthy, et al.
Infection Control and Hospital Epidemiology|October 28, 2025
Multisociety guidance for infection prevention and control in nursing homesLona Mody, Sonali D Advani, Muhammad Salman Ashraf, et al.
The Lancet. Oncology|May 4, 2019
Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 studyKenji Tamura, Junji Tsurutani, Shunji Takahashi, et al.
Journal of the Canadian Association of Gastroenterology|July 12, 2019
The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBDMatthew W Carroll, M Ellen Kuenzig, David R Mack, et al.
Nanotechnology|July 9, 2011
Efficient photogeneration of charge carriers in silicon nanowires with a radial doping gradientD H K Murthy, T Xu, W H Chen, et al.
The American Journal of Gastroenterology|December 29, 2022
REMIT-UC: Real-World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative Colitis: A Canadian IBD Research Consortium Multicenter National Cohort StudyChristopher Ma, Remo Panaccione, Yasi Xiao, et al.
The Journal of Clinical Investigation|February 3, 2011
An N-terminal truncated carboxypeptidase E splice isoform induces tumor growth and is a biomarker for predicting future metastasis in human cancersTerence K Lee, Saravana R K Murthy, Niamh X Cawley, et al.
Cancer|March 29, 2014
Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2-positive metastatic breast cancerRashmi K Murthy, Ankur Varma, Priyankana Mishra, et al.
Pageof 88

Showing results (761-770 of 873) with videos related to

Sort By:
Pageof 88
The Journal of Biological Chemistry|April 5, 2000
Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virusS Mummidi, M Bamshad, S S Ahuja, et al.
Infection Control and Hospital Epidemiology|December 9, 2020
Reliability of nonlocalizing signs and symptoms as indicators of the presence of infection in nursing-home residentsTheresa A Rowe, Robin L P Jump, Bjørg Marit Andersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2020
Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib StudyShanu Modi, Haeseong Park, Rashmi K Murthy, et al.
Infection Control and Hospital Epidemiology|October 28, 2025
Multisociety guidance for infection prevention and control in nursing homesLona Mody, Sonali D Advani, Muhammad Salman Ashraf, et al.
The Lancet. Oncology|May 4, 2019
Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 studyKenji Tamura, Junji Tsurutani, Shunji Takahashi, et al.
Journal of the Canadian Association of Gastroenterology|July 12, 2019
The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBDMatthew W Carroll, M Ellen Kuenzig, David R Mack, et al.
Nanotechnology|July 9, 2011
Efficient photogeneration of charge carriers in silicon nanowires with a radial doping gradientD H K Murthy, T Xu, W H Chen, et al.
The American Journal of Gastroenterology|December 29, 2022
REMIT-UC: Real-World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative Colitis: A Canadian IBD Research Consortium Multicenter National Cohort StudyChristopher Ma, Remo Panaccione, Yasi Xiao, et al.
The Journal of Clinical Investigation|February 3, 2011
An N-terminal truncated carboxypeptidase E splice isoform induces tumor growth and is a biomarker for predicting future metastasis in human cancersTerence K Lee, Saravana R K Murthy, Niamh X Cawley, et al.
Cancer|March 29, 2014
Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2-positive metastatic breast cancerRashmi K Murthy, Ankur Varma, Priyankana Mishra, et al.
Pageof 88